These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 27347638)

  • 1. An update of safety of clinically used atypical antipsychotics.
    Orsolini L; Tomasetti C; Valchera A; Vecchiotti R; Matarazzo I; Vellante F; Iasevoli F; Buonaguro EF; Fornaro M; Fiengo AL; Martinotti G; Mazza M; Perna G; Carano A; De Bartolomeis A; Di Giannantonio M; De Berardis D
    Expert Opin Drug Saf; 2016 Oct; 15(10):1329-47. PubMed ID: 27347638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-to-date expert opinion on the safety of recently developed antipsychotics.
    Orsolini L; De Berardis D; Volpe U
    Expert Opin Drug Saf; 2020 Aug; 19(8):981-998. PubMed ID: 32657173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight gain and antipsychotics: a drug safety review.
    Musil R; Obermeier M; Russ P; Hamerle M
    Expert Opin Drug Saf; 2015 Jan; 14(1):73-96. PubMed ID: 25400109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
    Baptista T; Kin NM; Beaulieu S; de Baptista EA
    Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of antipsychotic drugs: focus on therapeutic and adverse effects.
    Werner FM; Coveñas R
    Expert Opin Drug Saf; 2014 Aug; 13(8):1031-42. PubMed ID: 24975932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
    Bou Khalil R
    Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects of atypical antipsychotics : differential risk and clinical implications.
    Haddad PM; Sharma SG
    CNS Drugs; 2007; 21(11):911-36. PubMed ID: 17927296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of atypical antipsychotics: an update.
    Mauri MC; Paletta S; Maffini M; Colasanti A; Dragogna F; Di Pace C; Altamura AC
    EXCLI J; 2014; 13():1163-91. PubMed ID: 26417330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antipsychotic Treatment of the Adult Patient in the Acute Phase of Schizophrenia].
    Bohórquez Peñaranda A; Gómez Restrepo C; García Valencia J; Jaramillo González LE; de la Hoz AM; Arenas Á; Tamayo Martínez N
    Rev Colomb Psiquiatr; 2014; 44 Suppl 1():13-28. PubMed ID: 26576459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.
    Nasrallah HA
    Mol Psychiatry; 2008 Jan; 13(1):27-35. PubMed ID: 17848919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Pharmacokinetics of Atypical Antipsychotics: An Update.
    Mauri MC; Paletta S; Di Pace C; Reggiori A; Cirnigliaro G; Valli I; Altamura AC
    Clin Pharmacokinet; 2018 Dec; 57(12):1493-1528. PubMed ID: 29915922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium Neurotoxicity Due to Second-Generation Antipsychotics Combined With Lithium: A Systematic Review.
    Netto I; Phutane VH; Ravindran B
    Prim Care Companion CNS Disord; 2019 Jun; 21(3):. PubMed ID: 31237432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of atypical antipsychotics for the management of schizophrenia.
    Sprague DA; Loewen PS; Raymond CB
    Ann Pharmacother; 2004 Feb; 38(2):313-9. PubMed ID: 14742771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How the pharmacokinetics and receptor-binding profile of lurasidone affect the clinical utility and safety of the drug in the treatment of schizophrenia.
    Macaluso M; Kazanchi H; Preskorn SH
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1317-27. PubMed ID: 26173973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-emergent adverse events associated with atypical antipsychotics.
    Cha DS; McIntyre RS
    Expert Opin Pharmacother; 2012 Aug; 13(11):1587-98. PubMed ID: 22304541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.
    Schneider LS; Dagerman KS; Insel P
    JAMA; 2005 Oct; 294(15):1934-43. PubMed ID: 16234500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.